GEN Exclusives

More »

GEN News Highlights

More »
May 8, 2009

GE Healthcare to Provide Cytori’s Adipose-Derived Stem Cell Technology in North America

  • GE Healthcare agreed to commercialize Cytori Therapeutics’ StemSource® technology in the North American stem cell banking and research markets. The partnership will extend for 18 months starting in the second quarter of 2009.

    StemSource includes automated equipment to process stem and regenerative cells found in adipose tissue, cryopreserve them, or use them directly for research purposes.

    In January 2009, Cytori and GE Healthcare formed a separate agreement to commercialize Cytori’s products in 10 European countries. This includes selling the Celution® 800/CRS System in the European cosmetic and reconstructive surgery market as well as selling

    StemSource products in the European cell banking and research markets.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?